Clinical Trial Update: Aripiprazole Treatment of Bipolar Depression [Phase 4]

View source ↗

Summary

Aripiprazole was studied in a Phase 4 trial for bipolar depression. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Depression

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Indiana University School of Medicine | Conditions: Bipolar Depression | Phase 4 | Status: COMPLETED